Weekly updateCompaniesRecruiting servicePost a job
Appia Bio

Appia Bio

    Company info:

  • 1-50
  • 2020
  • Culver City, CA
  • 10-100M


appiabio.com

linkedin.com


Claim company profile

About company:

Appia Bio is developing off-the-shelf allogeneic cell therapies for cancer patients. Autologous cell therapies are expensive and time-consuming to make as some patients lack sufficient high quality cells to engineer. Instead, Appia is taking healthy donor hematopoietic stem cells and repurposing them to create chimeric antigen receptor (CAR)-engineered invariant natural killer T cells (iNKT) - a form of allogeneic cell therapy. iNKT cells are a powerful subtype of T cells that have multiple tumor cell-killing mechanisms but are exceedingly rare. Appia is mass producing the iNKTs and engineering them with a CAR to boost their response. These CAR-iNKTs are off-the-shelf allogeneic cell therapies that, once created, can be scaled on demand and deployed to cancer patients.

Jobs:

Appia Bio
Vice President, Clinical Operations
Culver City, CA|10 days ago
Appia Bio
Vice President, Regulatory Affairs
Culver City, CA|10 days ago
Appia Bio
Senior Director/Director, Facility Operations
Culver City, CA|66 days ago
Appia Bio
Scientist, Cell Therapy (Various Levels)
Los Angeles, CA|100+ days ago


© 2022 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com